JPMorgan analyst James Gordon raised the firm’s price target on Grifols (GRFS) to $10.30 from $7.60 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols Completes Acquisition of Biotest Shares Following Delisting
- Grifols Announces Leadership Changes and Financial Results at June 2025 Shareholders’ Meeting
- U.S. court rules to go on with Grifol lawsuit against Gotham City, Reuters says
- Grifols SA Reports Strong Q1 2025 Financial Performance
- Grifols SA Reports Strong Q1 2025 Earnings
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue